Compounding Pharmacies Market (By Product: Oral, Parenteral, Rectal, Topical, Ophthalmic, Others; By Therapeutic Area: Pain Management, Hormone Replacement Therapies, Dermatological Applications, Nutritional Supplement, Others; By Sterility: Non-sterile, Sterile) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global compounding pharmacies market size is poised to reach around US$ 14.3 Bn by 2026 and growing at a CAGR of around 6.2% over the forecast period 2019 to 2026.

Compounding pharmacy differs from traditional pharmacies. The role of the compounding pharmacy is to make drugs prescribed by physicians or specialists for specific patients as per their needs that cannot be met by marketed preparation. However, since the last decade scope of compounding pharmacies has been increased as these pharmacies are even helping to fulfill the drug shortage issue. Advantages associated with compounding pharmacies are they allow access to discontinued medications, make medications easy to use or administer, help to provide alternative dosage form for convenience, and make medications friendly for allergic patients. Compounded drugs are specifically utilized in pain management, hormone replacement, specialty drugs, dermatology and sometimes can be utilized as nutritional supplements. Regulatory authorities regularly monitor the compounding pharmacies activities for the safety of patients that helps to propel the market growth.

Market Dynamics

Increased in number of dispensed prescriptions across the globe due to an increase in the number of people suffering from diseases that require specialized formulations and shortage of medicines in developed regions are some of the key driving factors of the market. Developed regions such as Europe and North America have observed significant drug shortages for the last few years. This can be attributed to product quality issues, the inconsistent supply of raw materials, changing regulatory scenarios, and product delays. A shortage of medicines may have serious repercussions such as death or morbidity of patients. Timely availability of standard drugs by compounding pharmacies is anticipated to stimulate the demand for compounded medications thereby, boosting the market growth. However, the high cost of advanced equipment for compounding medicines and lack of skilled pharmacists and lab technicians may hamper the market growth to some extent.

Based on the product, the market has been segmented into oral, parenteral, rectal, topical, ophthalmic, and others. In 2018, the oral medications segment accounted for the maximum share of the market. The segment is further divided into tablets, capsules, lozenges, suspensions, and others. High demand from patients for oral medications due to ease of administration and transportation is a key factor for the dominance of the segment. Topical products are expected to observe the significant growth during the forecast period due to increasing allergic conditions and growing awareness about hormone replacement therapy. The topical medications segment can be further segmented into gels, creams,ointments, and others. Topical medications preferred for dermatological applications.

Based on the therapeutic areas, the global compounding pharmacies market is further divided into pain management, hormone replacement therapies, dermatological applications, nutritional supplement, and others. The pain management segment accounted for the maximum share of the market in 2018. Hormone replacement therapy is anticipated to boost the market growth with the fastest rate during the forecast period. This can be attributed to widening their applications in various conditions such as cancer and menopause. Furthermore, a shortage of these drugs in the U.S. and the requirement of variations in the formulations from patient to patient are the key factors for the high market growth. Demand for the nutritional supplement is increasing significantly and is anticipated to hold a substantial share during the forecast period. Unhealthy lifestyle and eating habits responsible for the requirement of external supplements and hence it is expected to observe a significant growth in the nutritional supplement demand at compounding pharmacies.

Based on the sterility of the formulation, the market has been divided into sterile and non-sterile dosage forms. In 2018, the non-sterile formulation segment accounted for the largest share of the market and is expected to propel the market growth during the forecast period.

Geographically, the market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America accounted for the largest share of the market and is anticipated to maintain its dominance during the forecast period. The shortage of drugs, increasing the geriatric population, and high healthcare awareness among people are the key factors for the dominance of the region. The Asia Pacific region is expected to observe the fastest growth during the forecast period. The growth can be attributed to the presence of a large geriatric population and people suffering from chronic diseases, the development of basic infrastructural facilities, and the entry of various players. China, India, Japan, and Singapore are some of the major contributing countries in the Asia Pacific.

The market research study on “Compounding Pharmacies Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight on the global compounding pharmacies market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global compounding pharmacies market, its product, therapeutic areas, sterility, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global compounding pharmacies market size and segment markets by product, therapeutic areas, sterility, and geography along with the information on companies operating in the market. The compounding pharmacies market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market sizes for different segments have been covered under the scope of the report.

Key players operating in the compounding pharmacies market are B. Braun Melsungen AG Company, Cantrell Drug Company, Dougherty’s Pharmacy, Fagron, Fresenius Kabi AG., Mcguff compounding pharmacy services, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, PharMEDium Services LLC, Triangle Lorraine’s Pharmacy, Village compounding Pharmacies, Wedgewood Village Pharmacy, and Rx3 Compounding Pharmacy. Mergers and acquisitions are some of the key strategies being adopted by the market players to enhance their share in the global market.     

Market Segmentation

Market By Product

  • Oral
  • Parenteral
  • Rectal
  • Topical
  • Ophthalmic
  • Others

By Therapeutic Area

  • Pain Management
  • Hormone Replacement Therapies
  • Dermatological Applications
  • Nutritional Supplement
  • Others

By Sterility

  • Non-sterile
  • Sterile

By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa


Frequently Asked Questions

The compounding pharmacy is to make drugs prescribed by physicians or specialists for specific patients as per their needs that cannot be met by marketed preparation.

Increased in number of dispensed prescriptions across the globe is main driver of the compounding pharmacies market.

According to Acumen Research and Consulting, the compounding pharmacies market value is anticipated to be worth around US$ 14.3 billion in 2026.

The compounding pharmacies market is anticipated to grow over 6.2% CAGR during the forecast period 2019 to 2026.

North America held maximum share in 2018 for compounding pharmacies market.

B. Braun Melsungen AG Company, Cantrell Drug Company, Dougherty’s Pharmacy, Fagron, Fresenius Kabi AG., Mcguff compounding pharmacy services, Institutional Pharmacy Solutions and ITC Compounding Pharmacy are the top players operating in the compounding pharmacies market.

In 2018, the oral medications segment accounted for the maximum share of the market.

Cart Summary


60